首页工具

搜索结果

Search Results for " ly-2228820 dimesylate "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T6047	Ralimetinib dimesylate LY2228820 dimesylate,Ralimetinib,LY2228820,Ralimetinib Mesylate	Apoptosis; p38 MAPK; Autophagy	Apoptosis; Autophagy; MAPK
	Ralimetinib dimesylate (LY2228820 dimesylate) 是一种选择性，ATP 竞争性的 p38 MAPK α/β抑制剂，IC50分别为5.3 和 3.2 nM。
T16721	Ralimetinib LY2228820	Others	Others
	Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor of p38 MAPK α/β (IC50s: 5.3 and 3.